NCT06852469View on ClinicalTrials.gov

Computational Assessment of GABA Receptor Modulation in PTSD

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Stress Disorders, Post-Traumatic
Interventions
DRUG

Lorazepam 1 mg tablet

Lorazepam is an oral medication which is FDA approved to treat anxiety.

DRUG

Placebo tablet

Placebo will match the study drug in mode of administration, color, size, and taste.

Trial Locations (1)

92161-0002

RECRUITING

VA San Diego Healthcare System, San Diego, CA, San Diego

All Listed Sponsors
lead

VA Office of Research and Development

FED